OMX Helsinki — S&P 500 — DAX — NASDAQ 100 — STOXX 600 — EUR/USD — EUR/SEK — BTC/USD — ETH/USD — Euribor 3M — Euribor 12M —
TechCrunch

TechCrunch

Startups and entrepreneurship 678,000 subscribers

Clipping out cancer with Caribou Biosciences | Disrupt NY 2017

09.10.2017 1,773 views
Published: 09.10.2017 Category: Startups and entrepreneurship Views: 1,773

Episode details

Episode description

Rachel Haurwitz of Caribou Biosciences talks to Sarah Buhr about what CRISPR makes possible, the ongoing IP battle over the tech, and the current regulatory environment. Subscribe to TechCrunch today: http://bit.ly/18J0X2e TechCrunch Disrupt is the world’s leading authority in debuting revolutionary startups, introducing game-changing technologies and discussing what’s top of mind for the tech industry’s key innovators. Watch more from Disrupt NY day two here: https://www.youtube.com/watch?v=mNJaRKiOYic TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

Open the AI assistant chat. The chat loads only when you open it.